Arkolith/Insider Trading/ACAD/Form 4

Kihara James

PRINCIPAL ACCOUNTING OFFICERACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Nov 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$97K
Net Open-Market Flow
-$97K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2025Sell(S)4K$23.69$97K25K
Nov 17, 2025Option exercise(M)4K——29K
Nov 17, 2025Option exercise(M)4K——25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 17, 2025Option exercise(M)4K—$00
Nov 17, 2025Option exercise(M)4K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001816160-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML